Yat Sun Or

2016

In 2016, Yat Sun Or earned a total compensation of $1.3M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals, a 22% decrease compared to previous year.

Compensation breakdown

Bonus$114,633
Non-Equity Incentive Plan$48,078
Option Awards$654,806
Salary$386,069
Stock Awards$122,428
Other$15,857
Total$1,341,871

Or received $654.8K in option awards, accounting for 49% of the total pay in 2016.

Or also received $114.6K in bonus, $48.1K in non-equity incentive plan, $386.1K in salary, $122.4K in stock awards and $15.9K in other compensation.

Rankings

In 2016, Yat Sun Or's compensation ranked 6,797th out of 14,075 executives tracked by ExecPay. In other words, Or earned more than 51.7% of executives.

ClassificationRankingPercentile
All
6,797
out of 14,075
52nd
Division
Manufacturing
2,537
out of 5,488
54th
Major group
Chemicals And Allied Products
827
out of 1,900
57th
Industry group
Drugs
636
out of 1,543
59th
Industry
Pharmaceutical Preparations
502
out of 1,173
57th
Source: SEC filing on January 19, 2018.

Or's colleagues

We found four more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2016.

2016

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2016

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

2016

Nathaniel Gardiner

Enanta Pharmaceuticals

General Counsel

2016

Nathalie Adda

Enanta Pharmaceuticals

Chief Medical Officer

News

You may also like